UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2024

 

Commission file number: 001-40231

 

Universe Pharmaceuticals INC

 

265 Jingjiu Avenue

Jinggangshan Economic and Technological Development Zone

Ji’an, Jiangxi, China 343100

+86-0796-8403309

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

Closing of Public Offering

 

On July 15, 2024, Universe Pharmaceuticals INC, a Cayman Islands company (the “Company”), closed its self-underwritten public offering (“Offering”) of 20,000,000 ordinary shares, par value $0.01875 per share (the “Ordinary Shares”). The Ordinary Shares were priced at $1.25 per share. The Company raised a total of $25 million through this Offering, before deducting Offering-related expenses.

 

This report does not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  Universe Pharmaceuticals INC.
   
Date: July 18, 2024 By: /s/ Gang Lai
    Gang Lai
    Chief Executive Officer

 

2

 

 


Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Universe Pharmaceuticals Charts.
Universe Pharmaceuticals (NASDAQ:UPC)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Universe Pharmaceuticals Charts.